Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country

doi:10.3748/wjg.v22.i43.9613

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 43

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7090)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-8) series.

Item

Count

PDF

476

WORD

230

HTML

3124

Figures (1-1)

161

Tables (1-8)

144

Sum=4135

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

982

Download

1973

Sum=2955

Nov 21, 2016 (publication date) through May 18, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Nov 21, 2016; 22(43): 9613-9622
Published online Nov 21, 2016. doi: 10.3748/wjg.v22.i43.9613

Table 6 Preliminary analysis of sustained virologic response outcome by treatment duration and prognostic baseline factors in patients with genotype 3 hepatitis C virus infection

Comparison or stratum	OR (95%CI)	P value
Age	1.02 (0.97-1.08)	0.432
Liver fibrosis (F3-4 vs F ≤ 2)	0.18 (0.05-0.67)	0.010
Sex (female vs male)	0.41 (0.14-1.16)	0.093
Treatment duration (48 wk vs 24 wk)	2.05 (0.42-9.92)	0.371

Citation: Hlaing NKT, Banerjee D, Mitrani R, Arker SH, Win KS, Tun NL, Thant Z, Win KM, Reddy KR. Hepatitis C virus therapy with peg-interferon and ribavirin in Myanmar: A resource-constrained country. World J Gastroenterol 2016; 22(43): 9613-9622
URL: https://www.wjgnet.com/1007-9327/full/v22/i43/9613.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i43.9613